HIND Vyome Holdings, Inc.
Vyome Holdings, Inc. (HIND) is expected to report earnings on November 11, 2026, before the market open. The stock has had a Post-Earnings Announcement Drift (PEAD) of -3.5% since its last earnings release on August 12, 2026.
Sign in or subscribe to unlock sentiment, short interest, and technical indicators.
Whisperings™
About Vyome Holdings, Inc.
Vyome Therapeutics Inc. is a clinical-stage healthcare company targeting immuno-inflammatory and rare diseases principally in the US. Vyome Therapeutics Inc., formerly known as ReShape Lifesciences Inc., is based in CAMBRIDGE, Mass.
Sector
Healthcare
Industry
Drug Manufacturers/Other